1-2 of 2 results for subject:X-rays
Librarians' tools
- Search time
- 0.152 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:X-rays
- We searched for
- subject_t:X-rays OR subject_ses:93524
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask His Majesty's Government whether they are considering using the new screening technology, developed by OsteoSight, for estimating bone mineral density from routine X-rays that has been approved by the Food and Drug Administration in the United States to give earlier diagnosis of osteoporosis.
To ask His Majesty's Government whether they are considering using the new screening technology, developed by OsteoSight, for estimating bone mineral density from routine X-rays that has been approved by the Food and Drug Administration in the United States to give earlier diagnosis of osteoporosis.
OsteoSight is not a registered product with the Medicines and Healthcare Products Regulatory Agency, therefore the Government is not currently considering the use of this technology. However, we will continue to explore areas where artificial intelligence can be deployed in health and care to support clinicians, transform patient experience and improve outcomes.
To ask Her Majesty's Government what assessment they have made of the adequacy of waiting times for access to a DXA bone density scan.
To ask Her Majesty's Government what assessment they have made of the adequacy of waiting times for access to a DXA bone density scan.
No formal assessment has been made. However, NHS England’s data as of January 2022 shows that 36.3% of patients waiting for DEXA scans have been waiting more than six weeks.